Haleon plc (HLN)

Haleon shows strong, defensive profitability (TTM gross margin ~64.77%, net margin ~15.11%) with manageable leverage (net debt/EBITDA ~2.59x) and healthy financial-strength indicators (Altman Z ~3.39). Multiples are mid-range (P/E ~19.90; EV/EBITDA ~14.20) while DCF outputs imply meaningful upside, but growth is modest and FX/regulatory risks remain. FundamentalScore: 4/5.

Dominant catalyst: market-rewarded GLP-1 side-effect demand strategy lifting US sales (product, announced, 2026-09-16). Sentiment delta determinate but cooling (+0.26 baseline vs ≈ +0.01 scoring, n=17); one moderate red flag fired — conflicting catalyst signals (rewarded GLP-1 sales lift vs newly filed Emergen-C 'Zero Sugar' labeling suit) — moderate red-flag cap applied.

HLN sits in a persistent downtrend: price 9.21 trades below the SMA20 (9.73), SMA50 (9.82) and SMA200 (9.83), below both EMA9/21 (9.39/9.59) and below the daily VWAP (9.24). Momentum is bearish — MACD line -0.18 under its signal (-0.10) with a widening negative histogram (-0.07), RSI14 at 34.26, Williams %R at -90 — and ADX 22.36 describes a moderate, direction-negative trend. The only bullish hook is the deeply oversold Williams reading after the slide from 9.86 to the 9.10 low of Sep 11, but any bounce-trade off the 9.10-9.20 support zone would be a countertrend bid: price is below the SMA50 with MACD < 0, and below a declining SMA200 (SMA50 < SMA200) with no momentum reclaim — the trend-alignment gate blocks it. Liquidity is enormous (~$114M/day, recent 3-session average ~$119M), so the name is tradeable in size, but the structure itself is not bullish; this is a bounce-only chart that scores 2/5.